BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30613000)

  • 1. Factors Associated With Efficacy of Cognitive Behavior Therapy vs Education for Patients With Irritable Bowel Syndrome.
    Lackner JM; Jaccard J;
    Clin Gastroenterol Hepatol; 2019 Jul; 17(8):1500-1508.e3. PubMed ID: 30613000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM; Jaccard J; Keefer L; Brenner DM; Firth RS; Gudleski GD; Hamilton FA; Katz LA; Krasner SS; Ma CX; Radziwon CD; Sitrin MD
    Gastroenterology; 2018 Jul; 155(1):47-57. PubMed ID: 29702118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H; Schrooten M; Ljótsson B; Boersma K; Linton S; Brummer RJ
    Scand J Pain; 2018 Jan; 18(1):81-91. PubMed ID: 29794287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific and common mediators of gastrointestinal symptom improvement in patients undergoing education/support vs. cognitive behavioral therapy for irritable bowel syndrome.
    Lackner JM; Jaccard J
    J Consult Clin Psychol; 2021 May; 89(5):435-453. PubMed ID: 34124927
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM; Chalder T; McCrone P; Darnley S; Knapp M; Jones RH; Wessely S
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive flexibility improves in cognitive behavioral therapy for irritable bowel syndrome but not nonspecific education/support.
    Lackner JM; Gudleski GD; Radziwon CD; Krasner SS; Firth RS; Naliboff BD; Vargovich AM; Borden AB; Mayer EA
    Behav Res Ther; 2022 Jul; 154():104033. PubMed ID: 35653934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
    Lackner JM; Jaccard J; Krasner SS; Katz LA; Gudleski GD; Holroyd K
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):899-906. PubMed ID: 18524691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT; Sibelli A; Moss-Morris R; van Tilburg MAL; Levy RL; Oser M
    Neurogastroenterol Motil; 2021 Nov; 33(11):e14108. PubMed ID: 33745228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.
    Hunt M; Miguez S; Dukas B; Onwude O; White S
    JMIR Mhealth Uhealth; 2021 May; 9(5):e26152. PubMed ID: 33872182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of symptomatic improvement after exposure-based treatment for irritable bowel syndrome.
    Ljótsson B; Andersson E; Lindfors P; Lackner JM; Grönberg K; Molin K; Norén J; Romberg K; Andersson E; Hursti T; Hesser H; Hedman E
    BMC Gastroenterol; 2013 Nov; 13():160. PubMed ID: 24245807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid response to cognitive behavior therapy predicts treatment outcome in patients with irritable bowel syndrome.
    Lackner JM; Gudleski GD; Keefer L; Krasner SS; Powell C; Katz LA
    Clin Gastroenterol Hepatol; 2010 May; 8(5):426-32. PubMed ID: 20170751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Group cognitive behavioural therapy (GCBT) versus treatment as usual (TAU) in the treatment of irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial.
    Kikuchi S; Oe Y; Sasaki Y; Ishii H; Ito Y; Horikoshi M; Sozu T; Seno H; Furukawa TA
    BMC Gastroenterol; 2020 Feb; 20(1):29. PubMed ID: 32019509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
    Hughes S; Sibelli A; Everitt HA; Moss-Morris R; Chalder T; Harvey JM; Vas Falcao A; Landau S; O'Reilly G; Windgassen S; Holland R; Little P; McCrone P; Goldsmith K; Coleman N; Logan R; Bishop FL
    J Med Internet Res; 2020 Nov; 22(11):e18691. PubMed ID: 33216002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How does cognitive behavior therapy for irritable bowel syndrome work? A mediational analysis of a randomized clinical trial.
    Lackner JM; Jaccard J; Krasner SS; Katz LA; Gudleski GD; Blanchard EB
    Gastroenterology; 2007 Aug; 133(2):433-44. PubMed ID: 17681164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.
    Lackner JM; Jaccard J; Radziwon CD; Firth RS; Gudleski GD; Hamilton F; Katz LA; Keefer L; Krasner SS; Ma CX; Sitrin MD; Brenner DM
    Am J Gastroenterol; 2019 Feb; 114(2):330-338. PubMed ID: 30429592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative Effect of Psychological Alterations on Gastrointestinal Symptom Severity in Irritable Bowel Syndrome.
    Midenfjord I; Borg A; Törnblom H; Simrén M
    Am J Gastroenterol; 2021 Apr; 116(4):769-779. PubMed ID: 33982947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain Catastrophizing and Clinical Outcomes Among Patients Receiving a Novel Cognitive-Behavioral Therapy for Irritable Bowel Syndrome: An Experimental Therapeutics Approach.
    Roger AH; Gudleski GD; Quigley BM; Zvolensky MJ; Lackner JM
    Behav Ther; 2023 Jul; 54(4):623-636. PubMed ID: 37330253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome.
    Windgassen S; Moss-Morris R; Chilcot J; Sibelli A; Goldsmith K; Chalder T
    Br J Health Psychol; 2017 Nov; 22(4):701-736. PubMed ID: 28573818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Symptoms of Irritable Bowel Syndrome Improve when Patients Receive Cognitive Behavioural Therapy for Co-morbid Anxiety Disorders in a Primary Care Psychological Therapy (IAPT) Service?
    Kenwright M; McDonald J; Talbot J; Janjua K
    Behav Cogn Psychother; 2017 Sep; 45(5):433-447. PubMed ID: 28478779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.